Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 16 studies | 72% ± 22% | |
astrocyte | 15 studies | 51% ± 19% | |
glutamatergic neuron | 13 studies | 49% ± 22% | |
GABAergic neuron | 8 studies | 33% ± 14% | |
interneuron | 5 studies | 27% ± 10% | |
neuron | 4 studies | 26% ± 7% | |
GABAergic interneuron | 3 studies | 21% ± 4% | |
granule cell | 3 studies | 37% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 33% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 856.46 | 2626 / 2642 | 96% | 32.06 | 676 / 705 |
prostate | 73% | 216.81 | 178 / 245 | 75% | 9.03 | 374 / 502 |
thymus | 81% | 217.14 | 531 / 653 | 0% | 0.01 | 2 / 605 |
esophagus | 47% | 243.46 | 679 / 1445 | 11% | 1.31 | 21 / 183 |
intestine | 49% | 216.29 | 472 / 966 | 6% | 0.41 | 30 / 527 |
lung | 46% | 72.71 | 263 / 578 | 5% | 0.41 | 52 / 1155 |
heart | 47% | 183.96 | 408 / 861 | 0% | 0 | 0 / 0 |
bladder | 19% | 45.38 | 4 / 21 | 4% | 0.79 | 18 / 504 |
breast | 1% | 1.51 | 5 / 459 | 18% | 8.73 | 206 / 1118 |
kidney | 16% | 18.22 | 14 / 89 | 3% | 0.21 | 26 / 901 |
adrenal gland | 3% | 3.85 | 7 / 258 | 10% | 1.89 | 24 / 230 |
blood vessel | 4% | 6.04 | 58 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.43 | 1 / 29 |
stomach | 1% | 0.49 | 2 / 359 | 3% | 0.28 | 8 / 286 |
uterus | 1% | 0.59 | 1 / 170 | 3% | 0.34 | 12 / 459 |
liver | 0% | 0 | 0 / 226 | 3% | 0.21 | 13 / 406 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.65 | 5 / 178 |
skin | 1% | 1.40 | 22 / 1809 | 1% | 0.13 | 6 / 472 |
ovary | 1% | 0.94 | 1 / 180 | 0% | 0.01 | 2 / 430 |
adipose | 1% | 1.44 | 11 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.50 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0021953 | Biological process | central nervous system neuron differentiation |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0007399 | Biological process | nervous system development |
GO_0005576 | Cellular component | extracellular region |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0030425 | Cellular component | dendrite |
Gene name | BRINP3 |
Protein name | BMP/retinoic acid inducible neural specific 3 BMP/retinoic acid-inducible neural-specific protein 3 (DBCCR1-like protein 1) |
Synonyms | DBCCR1L1 FAM5C DBCCR1L |
Description | FUNCTION: Inhibits neuronal cell proliferation by negative regulation of the cell cycle transition. Promotes pituitary gonadotrope cell proliferation, migration and invasion, when overexpressed. May play a role in cell pituitary tumor development. . |
Accessions | ENST00000631494.1 Q76B58 ENST00000367462.5 [Q76B58-1] B1AMP1 A0A0J9YVN8 ENST00000445957.2 |